The study found the 30mg/kg nipocalimab group had a statistically significant durable haemoglobin response by week 24.

Arialys Announces First ANRE Patient Treated with ART5803 in Open-Label Phase 2 Study and FDA Clearance of IND for Randomized Phase 2 Study ...

MBX Biosciences recently reported full 12-week Phase 2 Avail trial results and one-year open-label extension data for once-weekly canvuparatide in adults with chronic hypoparathyroidism, showing ...

Shell-led LNG Canada has issued a limited notice to proceed to its lead contractors for the proposed second phase for the liquefied natural gas export terminal in British Columbia, according to one of ...

Prediction of Treatment Efficacy in Locally Advanced Rectal Cancer Using a Clinical and Magnetic Resonance Imaging–Based Radiomics-Immunological Model for Total Neoadjuvant Therapy Fifty patients were ...